Prestwich Pharmacy Limited - Accounts to registrar (filleted) - small 18.2

Prestwich Pharmacy Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v21.2.0.376 04934939 Board of Directors 1.12.19 30.11.20 30.11.20 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure049349392019-11-30049349392020-11-30049349392019-12-012020-11-30049349392018-11-30049349392018-12-012019-11-30049349392019-11-3004934939ns16:EnglandWales2019-12-012020-11-3004934939ns15:PoundSterling2019-12-012020-11-3004934939ns11:Director12019-12-012020-11-3004934939ns11:PrivateLimitedCompanyLtd2019-12-012020-11-3004934939ns11:SmallEntities2019-12-012020-11-3004934939ns11:AuditExempt-NoAccountantsReport2019-12-012020-11-3004934939ns11:SmallCompaniesRegimeForDirectorsReport2019-12-012020-11-3004934939ns11:SmallCompaniesRegimeForAccounts2019-12-012020-11-3004934939ns11:FullAccounts2019-12-012020-11-3004934939ns11:Director22019-12-012020-11-3004934939ns11:Director32019-12-012020-11-3004934939ns11:Director42019-12-012020-11-3004934939ns11:CompanySecretary12019-12-012020-11-3004934939ns11:RegisteredOffice2019-12-012020-11-3004934939ns6:CurrentFinancialInstruments2020-11-3004934939ns6:CurrentFinancialInstruments2019-11-3004934939ns6:ShareCapital2020-11-3004934939ns6:ShareCapital2019-11-3004934939ns6:SharePremium2020-11-3004934939ns6:SharePremium2019-11-3004934939ns6:RetainedEarningsAccumulatedLosses2020-11-3004934939ns6:RetainedEarningsAccumulatedLosses2019-11-3004934939ns6:LeaseholdImprovements2019-12-012020-11-3004934939ns6:PlantMachinery2019-12-012020-11-3004934939ns6:FurnitureFittings2019-12-012020-11-3004934939ns6:LeaseholdImprovements2019-11-3004934939ns6:PlantMachinery2019-11-3004934939ns6:FurnitureFittings2019-11-3004934939ns6:LeaseholdImprovements2020-11-3004934939ns6:PlantMachinery2020-11-3004934939ns6:FurnitureFittings2020-11-3004934939ns6:LeaseholdImprovements2019-11-3004934939ns6:PlantMachinery2019-11-3004934939ns6:FurnitureFittings2019-11-3004934939ns6:CostValuation2019-11-3004934939ns6:CurrentFinancialInstrumentsns6:WithinOneYear2020-11-3004934939ns6:CurrentFinancialInstrumentsns6:WithinOneYear2019-11-30
REGISTERED NUMBER: 04934939 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 November 2020

for

PRESTWICH PHARMACY LIMITED

PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Contents of the Financial Statements
for the Year Ended 30 November 2020










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


PRESTWICH PHARMACY LIMITED

Company Information
for the Year Ended 30 November 2020







DIRECTORS: Mr F G McCaul
Mrs H Hughes
Mr H Hughes
Mr M Williams



SECRETARY: Mrs H Hughes



REGISTERED OFFICE: Century Buildings
14 St. Mary's Parsonage
Manchester
M3 2DF



REGISTERED NUMBER: 04934939 (England and Wales)



ACCOUNTANTS: BTMR Limited
Century Buildings
14 St Mary's Parsonage
Manchester
M3 2DF



BANKERS: Lloyds TSB Bank Plc
Burnley Branch
Burnley
Lancashire

PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Balance Sheet
30 November 2020

30.11.20 30.11.19
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 13,663 12,652
Investments 5 162,981 162,981
176,644 175,633

CURRENT ASSETS
Stocks 178,507 177,662
Debtors 6 317,902 237,082
Cash at bank and in hand 355,974 30,133
852,383 444,877
CREDITORS
Amounts falling due within one year 7 526,306 427,759
NET CURRENT ASSETS 326,077 17,118
TOTAL ASSETS LESS CURRENT
LIABILITIES

502,721

192,751

CAPITAL AND RESERVES
Called up share capital 10,004 10,004
Share premium 92,668 92,668
Retained earnings 400,049 90,079
SHAREHOLDERS' FUNDS 502,721 192,751

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2020.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2020 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 September 2021 and were signed on its behalf by:





Mr F G McCaul - Director


PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Notes to the Financial Statements
for the Year Ended 30 November 2020


1. STATUTORY INFORMATION

Prestwich Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is accounted for as revenue when, and to the extent that, the company obtains a right to consideration in exchange for its performance of its obligations under the sales contract with the customer. The amount reported as revenue is the fair value of the right to consideration - usually the price specified in the contractual arrangement net of discounts and net of VAT, and after any allowance for credit risk and other uncertainties.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Improvements to property - 10% on cost
Plant and machinery - 33% on cost
Fixtures and fittings - 33% on cost

Tangible fixed assets are initially recorded at cost.

Government grants
Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the company will comply with conditions attaching to them and the grants will be received using the accrual model.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2020


3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 30 (2019 - 26 ) .

4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and
property machinery fittings Totals
£    £    £    £   
COST
At 1 December 2019 554,610 246,793 287,440 1,088,843
Additions - 1,643 13,558 15,201
At 30 November 2020 554,610 248,436 300,998 1,104,044
DEPRECIATION
At 1 December 2019 554,610 245,285 276,296 1,076,191
Charge for year - 1,516 12,674 14,190
At 30 November 2020 554,610 246,801 288,970 1,090,381
NET BOOK VALUE
At 30 November 2020 - 1,635 12,028 13,663
At 30 November 2019 - 1,508 11,144 12,652

5. FIXED ASSET INVESTMENTS
Shares in
subsidiary
undertaki
ngs
£   
COST
At 1 December 2019
and 30 November 2020 162,981
NET BOOK VALUE
At 30 November 2020 162,981
At 30 November 2019 162,981

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.20 30.11.19
£    £   
Trade debtors 210,694 188,611
Other debtors 107,208 48,471
317,902 237,082

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.20 30.11.19
£    £   
Trade creditors 201,898 254,136
Taxation and social security 73,488 31,907
Other creditors 250,920 141,716
526,306 427,759

PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2020


8. ULTIMATE CONTROLLING PARTY

There is no controlling party